Emergent BioSolutions to webcast presentations
by Mary J. Lewis on November 3, 2009
CEO Fuad El-Hibri
ROCKVILLE, Md. — Emergent BioSolutions Inc. will webcast its presentation at two investor conferences in November.
The presentations will be made on Nov. 11 at the Southwest Ideas Conference in Dallas, and on Nov. 17 at the Lazard Capital Markets Healthcare Conference? in New York.
During each presentation, a member of the company’s senior management team will provide a corporate overview, including a discussion of product development programs, corporate activities and financial performance.
A webcast of these presentations will be available both live and by replay, accessible from the company’s website, www.emergentbiosolutions.com, under “Investors.”
Emergent BioSolutions focuses on vaccines and therapeutics that assist the body’s immune system. Its BioThrax is the only vaccine licensed by the U.S. Food and Drug Administration for the prevention of anthrax disease.
Programs focused on botulism, tuberculosis, typhoid, hepatitis B and Chlamydia are also in development.
More News
- Bangladesh faces another anthrax outbreak
- Anthrax found in dead English heroin user
- Bangladesh says anthrax outbreak is under control
- Bioterror experts meet in Kansas City, Missouri
- Achaogen receives BARDA contract to fight biowarfare agents
- Israel begins prepping for biological, chemical attacks
- Anthrax confirmed in Russia's Republic of Dagestan
- Purdue receives grant to identify pathogens in food
- Fla. man convicted of threatened biological weapon use
- IDF to release updated chemical attack treatment handbook
Read all news
Browse by Category
Browse by Location
Search
Subscribe to our newsletter
RSS Feed
